- Home
- PAGP vs SRRK Comparison
PAGP vs SRRK Comparison
Compare PAGP & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAGP
- SRRK
- Stock Information
- Founded
- PAGP 2013
- SRRK 2012
- Country
- PAGP United States
- SRRK United States
- Employees
- PAGP N/A
- SRRK N/A
- Industry
- PAGP Natural Gas Distribution
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAGP Energy
- SRRK Health Care
- Exchange
- PAGP Nasdaq
- SRRK Nasdaq
- Market Cap
- PAGP 3.3B
- SRRK 3.0B
- IPO Year
- PAGP 2013
- SRRK 2018
- Fundamental
- Price
- PAGP $17.65
- SRRK $29.66
- Analyst Decision
- PAGP Hold
- SRRK Strong Buy
- Analyst Count
- PAGP 8
- SRRK 9
- Target Price
- PAGP $19.86
- SRRK $47.88
- AVG Volume (30 Days)
- PAGP 1.4M
- SRRK 3.3M
- Earning Date
- PAGP 11-05-2025
- SRRK 11-14-2025
- Dividend Yield
- PAGP 8.62%
- SRRK N/A
- EPS Growth
- PAGP N/A
- SRRK N/A
- EPS
- PAGP 0.69
- SRRK N/A
- Revenue
- PAGP $47,796,000,000.00
- SRRK N/A
- Revenue This Year
- PAGP N/A
- SRRK N/A
- Revenue Next Year
- PAGP $11.23
- SRRK $1,911.27
- P/E Ratio
- PAGP $30.19
- SRRK N/A
- Revenue Growth
- PAGP N/A
- SRRK N/A
- 52 Week Low
- PAGP $16.61
- SRRK $22.71
- 52 Week High
- PAGP $22.31
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- PAGP 47.04
- SRRK 40.62
- Support Level
- PAGP $16.83
- SRRK $29.00
- Resistance Level
- PAGP $17.81
- SRRK $29.35
- Average True Range (ATR)
- PAGP 0.30
- SRRK 2.50
- MACD
- PAGP 0.09
- SRRK -0.81
- Stochastic Oscillator
- PAGP 75.89
- SRRK 12.63
About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.